Ubiquitin System: The Next Class of Drug Targets?
A Complex Role in Cellular Process & Growing Tool Set to Elucidate It
Bispecific Antibodies Close in on Cancer
Plotting Molecular Pincer Movements, Denying Cancer Room to Maneuver
Resolving Nonspecific Binding, Regeneration and Other Problems
Researchers Turn to Cloud Computing as Genomic Sequencing Data Threatens to Overwhelm Traditional IT Systems
For full access to this article login to GEN Select now.
Reformulations Must Provide Added Value
Novel Drugs Must Really Improve on the Original; Dosing Convenience Alone Is Not Enough
- Reformulating currently marketed pharmaceuticals is a common way to both improve drug performance and manage the life cycle of a brand. In the past, it was often sufficient for commercial success to develop only a more convenient dosing regimen, such as once-daily oral dosing from twice-daily oral dosing. ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.